Search Page

1

Cite

Share

Novel Biomarkers for Prostate Cancer Detection and Prognosis.

Filella X, Foj L. Filella X, et al. Adv Exp Med Biol. 2018;1095:15-39. doi: 10.1007/978-3-319-95693-0_2. Adv Exp Med Biol. 2018. PMID: 30229547 Review.

Cite

Share

2

Cite

Share

Emerging biomarkers in the diagnosis of prostate cancer.

Filella X, Fernández-Galan E, Fernández Bonifacio R, Foj L. Filella X, et al. Pharmgenomics Pers Med. 2018 May 16;11:83-94. doi: 10.2147/PGPM.S136026. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 29844697 Free PMC article. Review.

Cite

Share

3

Cite

Share

Prostate cancer screening: guidelines review and laboratory issues.

Filella X, Albaladejo MD, Allué JA, Castaño MA, Morell-Garcia D, Ruiz MÀ, Santamaría M, Torrejón MJ, Giménez N. Filella X, et al. Clin Chem Lab Med. 2019 Sep 25;57(10):1474-1487. doi: 10.1515/cclm-2018-1252. Clin Chem Lab Med. 2019. PMID: 31120856 Free article. Review.

Cite

Share

4

Cite

Share

miRNAs as novel biomarkers in the management of prostate cancer.

Filella X, Foj L. Filella X, et al. Clin Chem Lab Med. 2017 May 1;55(5):715-736. doi: 10.1515/cclm-2015-1073. Clin Chem Lab Med. 2017. PMID: 26751899 Free article. Review.

Cite

Share

5

Cite

Share

Study of Biocompatibility of Membranes in Online Hemodiafiltration.

Ojeda R, Arias-Guillén M, Gómez M, Vera M, Fontseré N, Rodas L, Filella X, Reverter JC, Lozano F, Villamor N, Maduell F. Ojeda R, et al. Among authors: filella x. Blood Purif. 2020;49(4):400-408. doi: 10.1159/000504954. Epub 2019 Dec 19. Blood Purif. 2020. PMID: 31865336

Cite

Share

6

Cite

Share

Emerging biomarkers in the detection and prognosis of prostate cancer.

Filella X, Foj L. Filella X, et al. Clin Chem Lab Med. 2015 Jun;53(7):963-73. doi: 10.1515/cclm-2014-0988. Clin Chem Lab Med. 2015. PMID: 25581761 Free article. Review.

Cite

Share

7

Cite

Share

Identification of Candidates for Active Surveillance: Should We Change the Current Paradigm?

Alcover J, Filella X. Alcover J, et al. Among authors: filella x. Clin Genitourin Cancer. 2015 Dec;13(6):499-504. doi: 10.1016/j.clgc.2015.06.001. Epub 2015 Jun 16. Clin Genitourin Cancer. 2015. PMID: 26194410 Review.

Cite

Share

8

Cite

Share

Circulating levels of HER-2/neu oncoprotein in breast cancer.

Molina R, Escudero JM, Muñoz M, Augé JM, Filella X. Molina R, et al. Among authors: filella x. Clin Chem Lab Med. 2012 Jan 4;50(1):5-21. doi: 10.1515/cclm.2011.822. Clin Chem Lab Med. 2012. PMID: 22505536 Review.

Cite

Share

9

Cite

Share

PCA3 in the detection and management of early prostate cancer.

Filella X, Foj L, Milà M, Augé JM, Molina R, Jiménez W. Filella X, et al. Tumour Biol. 2013 Jun;34(3):1337-47. doi: 10.1007/s13277-013-0739-6. Epub 2013 Mar 16. Tumour Biol. 2013. PMID: 23504524 Review.

Cite

Share

10

Cite

Share

Active surveillance in prostate cancer: the need to standardize.

Filella X, Alcover J, Molina R. Filella X, et al. Tumour Biol. 2011 Oct;32(5):839-43. doi: 10.1007/s13277-011-0193-2. Epub 2011 May 28. Tumour Biol. 2011. PMID: 21625940 Review.

Cite

Share